Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

TADAWUL:2070 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	184.32	122.14	160.07	335.35	328.32	331.07
Short-Term Investments	166.44	155	115.5	45	-	128.99
Trading Asset Securities	0.49	0.48	0.46	0.42	567.67	614.56
Cash & Short-Term Investments	351.25	277.62	276.03	380.77	895.99	1,075
Cash Growth	3.25%	0.58%	-27.51%	-57.50%	-16.62%	164.16%
Accounts Receivable	1,218	1,175	881.83	758.9	971.8	980.52
Other Receivables	30.09	63.3	35.42	147.12	94.29	102.88
Receivables	1,248	1,238	917.26	906.03	1,066	1,083
Inventory	635.88	646.09	589.21	494.69	419.09	458.06
Prepaid Expenses	241.5	18.56	22.98	23.73	23.99	18.6
Other Current Assets	-	175.7	103.17	70.56	57.16	39.87
Total Current Assets	2,477	2,356	1,909	1,876	2,462	2,675
Property, Plant & Equipment	1,758	1,748	1,825	1,829	1,818	1,827
Long-Term Investments	79.78	67.73	58.19	46.53	63.3	80.41
Other Intangible Assets	96.44	125.61	60.64	50.33	69.54	81.29
Long-Term Deferred Tax Assets	26.49	21.4	28.6	23.48	18.93	17.5
Long-Term Deferred Charges	-	-	-	6.67	1.9	1.55
Total Assets	4,438	4,319	3,881	3,832	4,434	4,683
Accounts Payable	573.56	446.3	318.98	223.01	303.65	345.99
Accrued Expenses	180.49	255.4	253.54	87.14	125.91	90.59
Short-Term Debt	381.78	-	2.05	197.32	170.15	270.17
Current Portion of Long-Term Debt	343.9	1,039	523.41	479.64	682.6	416.36
Current Portion of Leases	1.75	3.04	7.21	6.15	7.26	3.32
Current Income Taxes Payable	62.57	62.44	48.45	33.14	28.84	39.66
Other Current Liabilities	190.76	204.24	257.21	322.44	321.34	405.59
Total Current Liabilities	1,735	2,010	1,411	1,349	1,640	1,572
Long-Term Debt	697.82	462.46	575.28	379.83	417.12	649.07
Long-Term Leases	5.26	8.37	11.3	18.81	17.69	12.71
Long-Term Unearned Revenue	91.77	84.81	85.03	77.95	70.23	67.69
Pension & Post-Retirement Benefits	199.55	222.3	282.71	313.24	295.89	310.68
Total Liabilities	2,729	2,788	2,365	2,139	2,441	2,612
Common Stock	1,200	1,200	1,200	1,200	1,200	1,200
Retained Earnings	386	240.41	225.21	366.29	649.68	664.49
Treasury Stock	-19.94	-19.94	-8	-	-	-
Comprehensive Income & Other	-19.76	-42.17	-42.03	-26.79	-11.91	51.04
Total Common Equity	1,546	1,378	1,375	1,540	1,838	1,916
Minority Interest	162.12	153.02	140.42	153.6	155.64	155.43
Shareholders' Equity	1,708	1,531	1,516	1,693	1,993	2,071
Total Liabilities & Equity	4,438	4,319	3,881	3,832	4,434	4,683
Total Debt	1,431	1,513	1,119	1,082	1,295	1,352
Net Cash (Debt)	-1,079	-1,235	-843.22	-700.97	-398.82	-277.01
Net Cash Per Share	-9.05	-10.33	-7.05	-5.84	-3.32	-2.31
Filing Date Shares Outstanding	119.36	120	120	120	120	120
Total Common Shares Outstanding	119.36	120	120	120	120	120
Working Capital	741.71	346.18	497.79	526.94	822.58	1,103
Book Value Per Share	12.96	11.49	11.46	12.83	15.31	15.96
Tangible Book Value	1,450	1,253	1,315	1,489	1,768	1,834
Tangible Book Value Per Share	12.15	10.44	10.95	12.41	14.74	15.29
Land	-	115.87	120.93	122.04	122.05	122.27
Buildings	-	1,206	1,009	772.75	776.76	776.96
Machinery	-	1,319	1,196	1,106	1,107	1,104
Construction In Progress	197.84	149.01	483.48	753.81	686.46	672.49

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.